Su 30MKI – BrahMos Integration Successful
The Indian Air Force successfully fired the BrahMos air version missile from its frontline Su-30 MKI fighter aircraft. The air launched BrahMos missile, designed and developed by BrahMos Aerospace Private Limited (BAPL), is a 2.5 ton supersonic air to surface cruise missile with ranges close to 300 km.
The IAF became the first Air Force in the world to have successfully fired an air launched Trisonic class surface attack missile of this category on a sea target on 22 Nov 17.
This was followed by a second live launch over a land target on 22 May 19. The launch on 17 December is said to complete integration of the missile on Su-30MKI aircraft.
The software development and integration of weapon of the aircraft was undertaken by the IAF engineers while HAL carried out complex mechanical and electrical modifications on aircraft. The BrahMos missile provides Indian Air Force a much desired capability to strike form large stand-off ranges on any target at sea or on land with pinpoint accuracy by day or night and in all weather conditions.
On 17 December, the Defence Research & Development Organisation(DRDO), Indian Air Force (IAF) and BrahMos jointly successfully conducted two BrahMos supersonic cruise missiles tests today, one each from land and air platforms. The first missile launch was from a land based mobile launcher, where most of the components were indigenous, including themissile airframe,fuel management system and DRDO designed seeker.
Earlier on May 22, 2019, IAF had successfully tested the missile against a land-based target in the Car Nicobar Islands region.The BrahMosAir Launched Cruise Missile (ALCM) promises to bolster the air combat capability of IAF from stand-off ranges. Secretary, Department of Defence R&D and Chairman, DRDODr G Satheesh Reddy congratulated the DRDO, BrahMos and Air Force teams for the successful tests. Director General BrahMos Dr Sudhir Mishra, Defence Research & Development Laboratory Director Dr Dashrath Ram, and Director Integrated Test Range Dr Binoy Kumar Das were present during the trials.